CHANDRASEKARAN J, PARASURAMAN P, THEIVENDREN P, SUNDAR K, AMMUNJE DN, BALAYA RDA, KUNJIAPPAN S, . Prospects for repurposing FDA-approved medications as Omicron spike/ACE-2 protein complex disruptors. J.Res.Pharm. 2023;  27(4):  1605-1614. http://dx.doi.org/10.29228/jrp.445